How long does it take to lose weight?
Tirzepatide can reduce appetite quickly, but meaningful weight loss usually takes a few months. Your results depend on the dose you’re taking, whether you have diabetes, side effects from the medication and how long you stay on the treatment.
Patients typically begin taking Zepbound or Mounjaro, the brand names for tirzepatide, at a low dose that’s meant to get their body adjusted to the medication, not produce its full effect right away.
Weeks 1 to 2: Early appetite changes
Some people will feel less hungry, will feel fuller quicker or have less “food noise” within the first one to two weeks. You may see little progress on the scale at this point. Tirzepatide decreases your calorie intake by affecting your appetite, but the speed and strength of that effect vary from person to person.
Weeks 3 to 8: Early weight loss and dose increases
For many, early weight changes are more noticeable between weeks three and eight. You’re also likely increasing your dose: Zepbound begins at 2.5 milligrams for four weeks, then typically increases to 5 milligrams, with further increases at least four weeks apart if appropriate.
Months 3 to 8: More noticeable weight loss
Expect more noticeable progress between months three and eight, after you’ve reached and stayed on an effective dose. Your progress doesn’t have to stop after eight months, though. In a 72-week clinical trial of adults without diabetes, average weight loss ranged from 15% of starting body weight on 5 milligrams to 20.9% on 15 milligrams, alongside diet and exercise support.
Long-term results and plateaus
Weight loss slows over time, and plateauing is a normal part of that process. In an analysis of two tirzepatide trials, the typical plateau occurred around weeks 24 and 36, depending on starting BMI. Many participants continued losing weight longer, though most had plateaued by week 72.
If you haven’t lost any additional weight for a few weeks, it doesn’t mean your treatment has stopped working. In another trial, participants who continued tirzepatide after losing an average of 20.9% during the first 36 weeks lost an additional 5.5% over the course of the following year. If your progress has stalled for longer, talk to your doctor before changing your dose.
Tirzepatide weight loss timeline by dose
When you first take tirzepatide, you’ll begin at 2.5 milligrams once weekly for four weeks to help your body adjust. If you can tolerate this dose well, your doctor will increase your dose incrementally at least every four weeks.
It can be tempting to jump to higher doses quicker than you should, but this can cause gastrointestinal issues and hinder your progress. You don’t even need to reach the maximum 15 milligram dose for your treatment to be successful.
Tirzepatide dose timeline
| Dose | Typical timing if you increase every four weeks | Results | Common side effects |
|---|---|---|---|
| 2.5 mg | Weeks 1 to 4 starter dose | Appetite changes, scales changes (though modest) | Nausea, diarrhea, constipation, vomiting or stomach discomfort |
| 5 mg* | Week 5 and onward | Some people begin seeing steadier progress here | Stomach side effects can return after an increase, then ease with time |
| 7.5 mg | Weeks 9 to 12, if your doctor continues increasing your dose every four weeks | Appetite control continues | Nausea, diarrhea, constipation, vomiting or stomach discomfort |
| 10 mg* | Week 13 onward | This dose was linked to greater average loss than 5 mg in a 72-week trial | Nausea, diarrhea, constipation, vomiting or abdominal pain |
| 12.5 mg | Weeks 17 to 20, if your doctor continues increasing your dose every four weeks | Continued appetite control | Nausea, diarrhea, constipation, vomiting or stomach discomfort |
| 15 mg** | Week 21 onward | This dose produced the greatest average loss in the SURMOUNT-1 trial. | Gastrointestinal side effects remain the most common concern |
Which dose is linked to the greatest average weight loss?
In a 72-week trial, participants lost 15% of their starting body weight with 5 mg, 19.5% with 10 mg and 20.9% with 15 mg. While higher doses tend to lead to higher weight loss, the best dose is the one that you can tolerate and stay on. Experiencing gastrointestinal issues can set you back, so don’t be in a rush to jump to a higher dose before you’re ready.
How does tirzepatide compare with semaglutide?
When you compare tirzepatide and semaglutide, one similarity is that doses typically increase every four weeks to limit stomach upset. Semaglutide (Wegovy) reaches its standard maintenance dose at week 17, while tirzepatide reaches its maximum standard dosage in week 21. Overall, tirzepatide takes the crown. In a 72-week trial, tirzepatide led to 20.2% average weight loss versus 13.7% for semaglutide.
» MORE: Zepbound vs. Wegovy
Factors that change your weight loss speed
Your tirzepatide results won’t be the same as the next person. Your dose, starting weight, habits, genetics, health and ability to stay on your treatment can affect your results, along with the following:
- Starting weight: A 10% loss equals more pounds for someone who starts at a higher weight. You’ll want to track the percentage lost rather than just pounds.
- Dose and titration: You won’t see the full effect while taking the 2.5 mg starter dose. To minimize stomach upset, your doctor will increase your dose slowly.
- Weekly dosing: If you miss a dose, your progress will be inconsistent.
- Diet and activity: Tirzepatide works because it helps reduce your appetite, but if you’re eating only high-calorie foods and are sedentary, your results won’t be as strong. Clinical trials paired the medication with both diet and exercise.
- Side effects: Nausea, vomiting or diarrhea can affect your results. You’re more likely to experience these during dose increases. They often ease over time.
- Sleep: If you’re not getting enough sleep, you can experience an increase in hunger and eat more calories as a result.
- Health conditions and other medications: If you have health issues, you may have a different appetite and your body may use calories differently and lose weight differently.
» COMPARE: Top weight loss medication providers
What to do if weight loss stalls
Plateauing is a normal part of the weight loss process and doesn’t mean tirzepatide doesn’t work for you. In a clinical trial, researchers defined a plateau as being a less than 5% change over 12 weeks. If you don’t lose weight for a week, don’t panic.
- Make sure you’re actually stalled. Weigh yourself the first thing in the morning under similar conditions so that you can track your weight over weeks at a time rather than tracking day-to-day changes.
- Check your dose and injection schedule. If you’re still at a starter dose, you might not have reached your full treatment response.
- Review your food and drink intake. Hidden calories can sneak up on you. Track your meals, snacks and calories, and make sure you’re taking in enough protein and fiber.
- Reassess activity. During clinical trials, participants had to watch their intake and exercise.
FAQ
How can you tell if tirzepatide is working?
Tirzepatide can be working if you have less food noise, are getting fuller quicker and feel less hungry overall.
How long will it take to lose 50 pounds on tirzepatide?
It’s likely to take several months to lose 50 pounds on tirzepatide, although if you have a higher starting weight, you’ll reach that sooner than someone who weighs less. Your weight loss also depends on your dose and treatment response.
Is it normal to have no weight loss in the first week on tirzepatide?
Yes, it’s normal to have no weight loss during your first week of taking tirzepatide. You’re starting at a low 2.5 mg dose, and it takes time for the medicine to build up in your system.
Why am I not losing weight on tirzepatide?
If you’ve been consistent with your dose, are maintaining your diet and exercising, speak with your doctor. They may need to make an adjustment to your dose, or you could be in a normal plateau.
Article sources
ConsumerAffairs writers primarily rely on government data, industry experts and original research from other reputable publications to inform their work. Specific sources for this article include:
- U.S. Food and Drug Administration, "Highlights of Prescribing Information." Accessed Nov. 18, 2026.
- Massachusetts Medical Society, "Tirzepatide Once Weekly for the Treatment of Obesity." Accessed Nov. 18, 2026.
- National Center for Biotechnology Information, U.S. National Library of Medicine, "Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials." Accessed Nov. 18, 2026.
- National Center for Biotechnology Information, U.S. National Library of Medicine, "Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial." Accessed Nov. 18, 2026.
- U.S. Food and Drug Administration, "WEGOVY (semaglutide)." Accessed Nov. 18, 2026.
- The New England Journal of Medicine, "Tirzepatide as Compared with Semaglutide for the Treatment of Obesity." Accessed Nov. 18, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases, "Factors Affecting Weight & Health." Accessed Nov. 18, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases, "Eating & Physical Activity to Lose or Maintain Weight." Accessed Nov. 18, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases, "Treatment for Overweight & Obesity." Accessed Nov. 18, 2026.
